Drug Topics
MARCH 7, 2024
As pharmacy benefit managers gain leverage to continue driving up drug prices, local pharmacies struggle to keep up and Congress has been called to act—but it might be too late
Pharmacy Times
MARCH 5, 2024
Laws can help eliminate common barriers to transparency but are not the only way to achieve health care transparency.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Store News
MARCH 4, 2024
Ozempic and the Inflation Reduction Act represent seismic shifts in what pharmacies can offer its customers.
STAT
MARCH 8, 2024
Amylyx Pharmaceuticals said Friday that its treatment for ALS, called Relyvrio, failed to provide any benefit for patients in a large clinical trial — a stunning outcome that now has the company considering a voluntary withdrawal of the approved medicine from the market. “This is really hard for us, and it’s really hard for our team who care so much, but it’s so much harder for people with ALS and their families, and we have to keep that perspective,” said a so
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Topics
MARCH 4, 2024
Although the pandemic spurred a greater need and use of online health resources, certain demographics continue to report significantly low participation in digital health portals.
Pharmacy Times
MARCH 8, 2024
Semaglutide (Wegovy; Novo Nordisk) reduces the risk of cardiovascular death, heart attack, and stroke in adults with cardiovascular disease and either obesity or overweight when combined with the standard-of-care.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
MARCH 8, 2024
The latest disappointment in amyotrophic lateral sclerosis research brought crushing news for patients and physicians, forcing the community to consider just what to do with an approved medicine that doesn’t appear to work. Amylyx Pharmaceuticals’ announcement Friday that its drug, marketed as Relyvrio, failed to beat placebo in a pivotal study marks “a sad day for us, but we have to believe the data,” said Mary Catherine Collet, an ALS advocate.
Drug Topics
MARCH 5, 2024
Health care professionals, industry leaders, and politicians gathered for a virtual roundtable to discuss the state of the PBM industry.
Pharmacy Times
MARCH 6, 2024
Findings emphasize the importance of further research on effective and safe alternative treatments for MDD in children and adolescents, specifically in patients who are refractory to nonpharmacologic treatment and/or standard of care antidepressants
Fierce Healthcare
MARCH 6, 2024
One of the largest health IT conferences, HIMSS24, will kick off in Orlando on Monday as a revamped trade show following a deal with Informa Markets last fall. | One of the largest health IT conferences, HIMSS24, will kick off in Orlando on Monday as a revamped trade show following a deal with Informa Markets last fall.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
MARCH 7, 2024
Medical students at Albert Einstein School of Medicine in New York City gathered last week to hear a life-changing announcement: Ruth Gottesman revealed she would be donating $1 billion, ensuring no student at Einstein will pay tuition ever again. Leadership at Albert Einstein School of Medicine celebrated the donation as a means to attract a more diverse student body.
Drug Topics
MARCH 7, 2024
Mind Medicine’s lysergide d-tartrate (MM120) demonstrated statistically significant and clinically meaningful improvements in anxiety symptoms in a phase 2b study.
Pharmacy Times
MARCH 8, 2024
In the State of the Union Address, President Biden said he wants to expand the $2,000 out-of-pocket cap beyond seniors and allow Medicare to negotiate more costly drugs.
Fierce Healthcare
MARCH 7, 2024
Mark Cuban Cost Plus Drug Company has found its first national health system buyer for hospital drugs currently in short supply. | The 71-hospital for-profit is the first national health system buyer to cut a deal with the billionaire-backed generic drug maker. The companies are kicking off their partnership in CHS' Texas and Pennsylvania hospitals.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
MARCH 7, 2024
Zaria was just 9 years old when a nurse practitioner delivered news that rocked her world: The young girl was already showing signs of puberty development, and she was on track to get her period within the next year. Surprised by this timeline, Zaria’s mother, Chanell, worked with a pediatrician to plan healthier meals, hoping that managing her daughter’s weight gain could give her a couple more precious years with her childhood unchanged.
Drug Topics
MARCH 6, 2024
The statement says the agency is talking with CMS to initiate new flexibilities, but multiple advocacy groups have said it’s not nearly enough.
Pharmacy Times
MARCH 5, 2024
The next-generation SRI was previously granted an Orphan Drug Designation in November 2023 and its safety and efficacy are currently being evaluated in clinical trials.
Fierce Pharma
MARCH 8, 2024
Novo Nordisk’s fast-growing weight loss med Wegovy just added a new cardiovascular FDA approval to its label, likely enabling the med's superstar status to reach new levels. | The drug is the first weight loss treatment to win FDA approval to reduce the risk of severe cardiovascular outcomes, giving it an edge over rival Zepbound from Eli Lilly.
STAT
MARCH 7, 2024
A new monoclonal antibody product to protect against respiratory syncytial virus was 90% effective at preventing little children from being hospitalized with RSV, according to new data from the first season it was in use. The data , published Thursday in Morbidity and Mortality Weekly Report, a Centers for Disease Control and Prevention publication, looked at how well Beyfortus worked in the children whose parents managed to secure a scarce dose of the drug.
Drug Topics
MARCH 7, 2024
The out-of-pocket price cap applies to all inhalers in the company’s portfolio and will launch on June 1, 2024.
Pharmacy Times
MARCH 5, 2024
Denosumab-bbdz (Wyost; Sandoz) and denosumab-bbdz (Jubbonti; Sandoz) are approved as interchangeable for all indications of Xgeva (denosumab; Amgen) and Prolia (denosumab; Amgen).
pharmaphorum
MARCH 4, 2024
Inhaled cannabinoids have been shown to perform better than placebo in providing pain relief for people suffering from acute migraine in a clinical trial
STAT
MARCH 7, 2024
A new study shows that some nursing homes are shunting the majority of their profits off of their own books and into less-visible corners of their owners’ pockets. The practice makes the nursing homes look poorer than they really are, the study’s authors wrote, which seems to bolster the industry’s arguments to Congress that it can’t meet certain proposed quality standards or handle potential Medicare payment cuts.
Drug Topics
MARCH 5, 2024
Dexcom's Stelo will be available in summer 2024.
Pharmacy Times
MARCH 6, 2024
This episode highlights how celebrity endorsements and local influencers can be leveraged to address vaccine hesitancy by shaping attitudes, but also must account for factors like audience trust and the potential for both benefits and limitations.
Fierce Healthcare
MARCH 4, 2024
Mark Cuban Cost Plus Drugs Company will begin manufacturing its own generic medications this week, starting with sterile injectables, founder and CEO Dr. | Mark Cuban Cost Plus Drugs Company will begin manufacturing its own generic medications this week, starting with sterile injectables, founder and CEO Dr. Alex Oshmyansky said Monday during a White House roundtable on lowering healthcare costs.
STAT
MARCH 6, 2024
On Sunday, public health officials in two Michigan counties warned their residents that they may have been exposed to measles. In Wayne County , an adult who had contracted the virus abroad had been in health-related settings in Dearborn on two days last week — two urgent care clinics, a CVS pharmacy, and a hospital emergency department. Health officials in neighboring Washtenaw County issued a similar alert about a different case — also an adult, also infected abroad —
Fierce Pharma
MARCH 4, 2024
When Pfizer completed its $43 billion buyout of Seagen in December | Less than three months after completing its $43 billion acquisition of Seagen, Pfizer has confirmed a report that it is shutting down construction of a $350 million manufacturing facility in Everett, Washington. The decision will affect 120 employees working on the initial setup of the site, the company said.
Pharmacy Times
MARCH 8, 2024
The vice president and chief pharmacy officer at City of Hope explains how she serves as a mentor for women within health care, the importance of networking, and staying educated.
Fierce Healthcare
MARCH 5, 2024
Humana and Elevance Health said they are seeing a 15% to 20% reduction in data from providers after the Change Healthcare hack, company execs said during an industry conference March 5. | Both Humana and Elevance Health said the Change Healthcare cyberattack is affecting its claims data from providers. The plans are increasingly relying on Availity, a competing clearinghouse to handle claims processing.
STAT
MARCH 6, 2024
Micro and nanoplastics, tiny pieces of plastic scattered throughout the environment, have been increasingly found to be able to enter the body, raising questions about where they end up and how they affect people’s health. In a new study, researchers say they have for the first time detected these plastic pieces inside fatty plaques that accumulate in blood vessels and linked them to an increased rate of heart problems.
Fierce Pharma
MARCH 7, 2024
As one of Boehringer Ingelheim's asthma competitors catches scrutiny over pricing and access concerns, the company itself is taking steps to cut patient costs in the U.S. | Starting on June 1, patients will only have to shell out a maximum of $35 per month for Boehringer Ingelheim inhalers in the U.S.
Pharmacy Times
MARCH 7, 2024
Tune into this episode of “Public Health Matters” for valuable insights into the intersection of entertainment, health care, and child advocacy, highlighting the importance of creating supportive and interactive environments for pediatric patients.
Fierce Healthcare
MARCH 8, 2024
Community pharmacies are well positioned to make a difference in the lives of their patients by providing convenient access to quality, affordable clinical pharmacy services while closing gaps in c | The current environment of decreasing reimbursement and increasing drug costs is not sustainable for either chain or independent pharmacies.
Expert insights. Personalized for you.
243 
Let's personalize your content